Determining an optimal clinical dose of elobixibat, a novel inhibitor of the ileal bile acid transporter, in Japanese patients with chronic constipation: a phase II, multicenter, double-blind, placebo-controlled randomized clinical trial
ConclusionsOur study results suggest that 10 mg of elobixibat is a clinically optimal dose for Japanese patients with chronic constipation.Clinical trial registration numberJapicCTI-142608.
Source: Journal of Gastroenterology - Category: Gastroenterology Source Type: research
More News: Bile | Chronic Pain | Clinical Trials | Constipation | Gastroenterology | Irritable Bowel Syndrome | Japan Health | Pain | Study